Southern Research has invested in a diverse set of small molecules to support HTS and virtual screening efforts for our partners. Our full screening collection consists of over 750,000 diverse drug-like compounds. Within our full collection exists 10,000 compounds of known biological action across 600 targets including FDA-approved drugs and other clinically tested compounds. The combination of our collection with our assay capabilities supports your path to discovery.